Vitamin D Pilot Study in Patients With Multiple Sclerosis

• Status: Completed
• Trial end date: 2000-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Wisconsin, Madison
• Treatments: Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• relapsing remitting MS

Exclusion Criteria:

• MRI contraindicated